Overview

Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The study objective is to evaluate advantages and disadvantages of Neupro® versus oral anti-Parkinson medication by caregivers and physicians in idiopathic Parkinson's Disease patients requiring caregiver support in nursing home or outpatient care settings.
Details
Lead Sponsor:
UCB Pharma
Treatments:
N 0437
Rotigotine